Freedberg KA - Search Results

1

Routine human immunodeficiency virus testing: an economic evaluation of current guidelines.

Walensky RP, Weinstein MC, Kimmel AD, Seage GR 3rd, Losina E, Sax PE, Zhang H, Smith HE, Freedberg KA, Paltiel AD. Walensky RP, et al. Among authors: freedberg ka. Am J Med. 2005 Mar;118(3):292-300. doi: 10.1016/j.amjmed.2004.07.055. Am J Med. 2005. PMID: 15745728

2

Optimal management strategies for HIV-infected patients who present with cough or dyspnea: a cost-effective analysis.

Freedberg KA, Tosteson AN, Cotton DJ, Goldman L. Freedberg KA, et al. J Gen Intern Med. 1992 May-Jun;7(3):261-72. doi: 10.1007/BF02598081. J Gen Intern Med. 1992. PMID: 1351940 Review.

3

A model clinic for the initial evaluation and establishment of primary care for persons infected with human immunodeficiency virus.

Samet JH, Libman H, LaBelle C, Steger K, Lewis R, Craven DE, Freedberg KA. Samet JH, et al. Among authors: freedberg ka. Arch Intern Med. 1995 Aug 7-21;155(15):1629-33. Arch Intern Med. 1995. PMID: 7618986

4

AIDS among the homeless of Boston: a cohort study.

Lebow JM, O'Connell JJ, Oddleifson S, Gallagher KM, Seage GR 3rd, Freedberg KA. Lebow JM, et al. Among authors: freedberg ka. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Mar 1;8(3):292-6. doi: 10.1097/00042560-199503010-00011. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7859142

5

Factors associated with initiation of primary medical care for HIV-infected persons.

Samet JH, Retondo MJ, Freedberg KA, Stein MD, Heeren T, Libman H. Samet JH, et al. Among authors: freedberg ka. Am J Med. 1994 Oct;97(4):347-53. doi: 10.1016/0002-9343(94)90301-8. Am J Med. 1994. PMID: 7942936 Free article.

6

The cost-effectiveness of fluconazole prophylaxis against primary systemic fungal infections in AIDS patients.

Scharfstein JA, Paltiel AD, Freedberg KA. Scharfstein JA, et al. Among authors: freedberg ka. Med Decis Making. 1997 Oct-Dec;17(4):373-81. doi: 10.1177/0272989X9701700402. Med Decis Making. 1997. PMID: 9343795

7

The cost-effectiveness of preventing AIDS-related opportunistic infections.

Freedberg KA, Scharfstein JA, Seage GR 3rd, Losina E, Weinstein MC, Craven DE, Paltiel AD. Freedberg KA, et al. JAMA. 1998 Jan 14;279(2):130-6. doi: 10.1001/jama.279.2.130. JAMA. 1998. PMID: 9440663

8

A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infection.

Paltiel AD, Scharfstein JA, Seage GR 3rd, Losina E, Goldie SJ, Weinstein MC, Craven DE, Freedberg KA. Paltiel AD, et al. Among authors: freedberg ka. Med Decis Making. 1998 Apr-Jun;18(2 Suppl):S93-105. doi: 10.1177/0272989X98018002S11. Med Decis Making. 1998. PMID: 9566470

9

The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.

Goldie SJ, Weinstein MC, Kuntz KM, Freedberg KA. Goldie SJ, et al. Among authors: freedberg ka. Ann Intern Med. 1999 Jan 19;130(2):97-107. doi: 10.7326/0003-4819-130-2-199901190-00003. Ann Intern Med. 1999. PMID: 10068381

10

Cost effectiveness of prophylaxis for opportunistic infections in AIDS. An overview and methodological discussion.

Freedberg KA, Paltiel AD. Freedberg KA, et al. Pharmacoeconomics. 1998 Aug;14(2):165-74. doi: 10.2165/00019053-199814020-00005. Pharmacoeconomics. 1998. PMID: 10186457 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

357 results

Search Page